Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7773]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Treating women with endocrine-resistant HR /HER2 advanced breast cancer
Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie...
Treating women with endocrine-resistant HR /HER2 advanced breast cancer ( Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. )
11 Dec 2015
No significant difference in recurrence rates among women with DCIS taking...
Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United...
No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )
11 Dec 2015
Patients with DCIS receiving anastrozole reported symptoms different from those...
Prof Patricia Ganz - UCLA, Los Angeles, USA
Patients with DCIS receiving anastrozole reported symptoms different from those receiving tamoxifen both groups reported similar quality of life ( Prof Patricia Ganz - UCLA, Los Angeles, USA )
11 Dec 2015
Improved survival outcomes in women with HER2-negative breast cancer after...
Dr Masakazu Toi - Kyoto university, Kyoto, Japan
Improved survival outcomes in women with HER2-negative breast cancer after neoadjuvant chemotherapy ( Dr Masakazu Toi - Kyoto university, Kyoto, Japan )
10 Dec 2015
Denosumab improves disease-free survival for postmenopausal patients with HR...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
9 Dec 2015
Denosumab improves disease-free survival for postmenopausal HR-positive breast...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
9 Dec 2015
How is cancer-related venous thromboembolism treated in real world practice?
Prof Alok Khorana - Cleveland Clinic, Cleveland, USA
How is cancer-related venous thromboembolism treated in real world practice? ( Prof Alok Khorana - Cleveland Clinic, Cleveland, USA )
7 Dec 2015
Obesity provides a fertile ground for cancer to grow
Dr Michael Pollack - McGill University, Montreal, Canada
Obesity provides a fertile ground for cancer to grow ( Dr Michael Pollack - McGill University, Montreal, Canada )
7 Dec 2015
Dalteparin thromboprophylaxis for cancer patients at high risk of venous...
Prof Alok Khorana - Cleveland Clinic, Cleveland, USA
Dalteparin thromboprophylaxis for cancer patients at high risk of venous thromboembolism ( Prof Alok Khorana - Cleveland Clinic, Cleveland, USA )
7 Dec 2015
Chemoprevention in breast cancer and possible vaccine for prostate cancer
Dr Leslie Ford - National Cancer Institute, Rockville, USA
Chemoprevention in breast cancer and possible vaccine for prostate cancer ( Dr Leslie Ford - National Cancer Institute, Rockville, USA )
7 Dec 2015
The impact of microbiota on the immune response
Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA
The impact of microbiota on the immune response ( Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA )
7 Dec 2015
High dose chemotherapy plus transplant remains standard care for young newly...
Dr Francesca Gay - University of Torino, Torino, Italy
High dose chemotherapy plus transplant remains standard care for young newly diagnosed multiple myeloma patients ( Dr Francesca Gay - University of Torino, Torino, Italy )
7 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation